• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪肝疾病与肥胖症对心血管疾病发病风险的交互作用。

Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases.

机构信息

Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou, 730000, China.

出版信息

Sci Rep. 2024 Oct 14;14(1):24024. doi: 10.1038/s41598-024-74841-3.

DOI:10.1038/s41598-024-74841-3
PMID:39402185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11473819/
Abstract

BACKGROUNDS

This investigation seeks to explore the correlation between nonalcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVDs), and to to provide evidence for the prevention and treatment of CVDs.

METHODS

This study utilized data from the Jinchang cohort platform, including 19,399 participants without pre-existing major CVDs. Based on the general population and gender stratification, Cox models were used to analyze the risk of NAFLD for CVDs. The combined effect of NAFLD and different obesity indicators on CVDs was analyzed by additive and multiplicative interaction models and subgroups.

RESULTS

There were 3129 NAFLD patients out of 19399 subjects, and 723 (23.11%) of them had the CVD. After adjusting for multiple confounding factors, the Cox model revealed a 1.17-fold increase in the risk of CVDs among patients with NAFLD compared to those without NAFLD. Moreover, there was no notable disparity in CVDs risk among most NAFLD patients at the same level of obesity. The results indicated no additive interaction between NAFLD and obesity concerning CVDs risk, but rather a positive multiplicative interaction. Using the normal population as a reference, it was found that people with both obesity and NAFLD significantly increased the risk of developing CVDs, with HRs and 95% CIs of 1.790 (1.508, 2.126), 1.356 (1.213, 1.517), and 1.807 (1.503, 2.174), respectively, for BMI, WC, and the combination of BMI and WC.

CONCLUSIONS

NAFLD and obesity are independent risk factors for CVDs. The synergy of obesity and NAFLD implies that NAFLD patients should control weight gain. Larger BMI and WC values may increase the CVDs risk for NAFLD patients, especially women.

摘要

背景

本研究旨在探讨非酒精性脂肪性肝病(NAFLD)与心血管疾病(CVDs)之间的相关性,为 CVDs 的防治提供依据。

方法

本研究利用金昌队列平台的数据,纳入 19399 例无既往重大 CVDs 的参与者。基于普通人群和性别分层,采用 Cox 模型分析 NAFLD 对 CVDs 的发病风险。采用加性和乘法交互模型及亚组分析,探讨 NAFLD 与不同肥胖指标对 CVDs 的联合作用。

结果

19399 例受试者中,有 3129 例患有 NAFLD,其中 723 例(23.11%)患有 CVD。调整多个混杂因素后,Cox 模型显示,与无 NAFLD 者相比,NAFLD 患者 CVDs 的发病风险增加 1.17 倍。而且,大多数 NAFLD 患者在肥胖程度相同时,其 CVDs 发病风险无明显差异。结果表明,NAFLD 与肥胖对 CVDs 风险无明显的加性交互作用,而存在正的乘法交互作用。以普通人群为参照,发现肥胖且患有 NAFLD 的人群发生 CVDs 的风险显著增加,HR 值及其 95%CI 分别为 1.790(1.508,2.126)、1.356(1.213,1.517)和 1.807(1.503,2.174),分别对应 BMI、WC 及 BMI 和 WC 的组合。

结论

NAFLD 和肥胖是 CVDs 的独立危险因素。肥胖和 NAFLD 的协同作用提示 NAFLD 患者应控制体重增加。更大的 BMI 和 WC 值可能会增加 NAFLD 患者的 CVDs 发病风险,尤其是女性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a60/11473819/510281522771/41598_2024_74841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a60/11473819/510281522771/41598_2024_74841_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a60/11473819/510281522771/41598_2024_74841_Fig1_HTML.jpg

相似文献

1
Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases.非酒精性脂肪肝疾病与肥胖症对心血管疾病发病风险的交互作用。
Sci Rep. 2024 Oct 14;14(1):24024. doi: 10.1038/s41598-024-74841-3.
2
The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.联合简单人体测量肥胖参数,即体重指数(BMI)和体脂指数(ABSI),评估非酒精性脂肪性肝病风险的价值。
Lipids Health Dis. 2022 Oct 20;21(1):104. doi: 10.1186/s12944-022-01717-8.
3
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.非肥胖非酒精性脂肪性肝病患者的心血管疾病风险。
Hepatol Commun. 2022 Feb;6(2):309-319. doi: 10.1002/hep4.1818. Epub 2021 Sep 2.
4
Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.非肥胖血脂正常人群中甘油三酯-葡萄糖-体重指数与非酒精性脂肪肝的相关性:基于前瞻性队列研究的二次分析。
Lipids Health Dis. 2020 Oct 28;19(1):229. doi: 10.1186/s12944-020-01409-1.
5
Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective.体重减轻打破非酒精性脂肪性肝病与心血管疾病之间的关联:临床和流行病学视角。
Obes Rev. 2023 Jun;24(6):e13563. doi: 10.1111/obr.13563. Epub 2023 Mar 23.
6
[Association between regional fat mass and risk of nonalcoholic fatty liver disease in overweight/obese adults].超重/肥胖成年人局部脂肪量与非酒精性脂肪性肝病风险之间的关联
Wei Sheng Yan Jiu. 2022 Sep;51(5):753-760. doi: 10.19813/j.cnki.weishengyanjiu.2022.05.013.
7
Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.瘦型非酒精性脂肪性肝病与中国西北地区健康人群 2 型糖尿病发病风险的关联:一项 2 年随访期的回顾性队列研究。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1173757. doi: 10.3389/fendo.2023.1173757. eCollection 2023.
8
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
9
Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.骨骼肌量和腹型肥胖是肝脂肪变性的独立预测因子,两者相互作用可预测十年心血管疾病的发生率:来自 ATTICA 队列研究的数据。
Clin Nutr. 2022 Jun;41(6):1281-1289. doi: 10.1016/j.clnu.2022.03.022. Epub 2022 Mar 31.
10
What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?新指标相对脂肪量(RFM)在非酒精性脂肪性肝病(NAFLD)评估中的作用是什么?
Obes Surg. 2020 Feb;30(2):560-568. doi: 10.1007/s11695-019-04213-8.

引用本文的文献

1
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk.代谢功能障碍相关脂肪性肝病:与心血管风险的发病机制联系
Biomolecules. 2025 Jan 22;15(2):163. doi: 10.3390/biom15020163.

本文引用的文献

1
The prevalence of obesity-related hypertension among middle-aged and older adults in China.中国中老年人群中肥胖相关性高血压的患病率。
Front Public Health. 2022 Nov 24;10:865870. doi: 10.3389/fpubh.2022.865870. eCollection 2022.
2
Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China.非酒精性脂肪性肝病的瘦、超重和肥胖受试者的结局:中国的一项队列研究。
Hepatol Commun. 2022 Dec;6(12):3393-3405. doi: 10.1002/hep4.2081. Epub 2022 Oct 25.
3
Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.
非酒精性脂肪性肝病:一种新出现的现代心血管疾病风险因素。
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495. eCollection 2022 May.
4
Cohort Profile Update: the China Metal-Exposed workers Cohort Study (Jinchang Cohort).队列资料更新:中国金属暴露工人队列研究(金昌队列)。
Eur J Epidemiol. 2022 Jun;37(6):641-649. doi: 10.1007/s10654-022-00875-4. Epub 2022 Jun 17.
5
[Expert Consensus on Obesity Prevention and Treatment in China].《中国肥胖防治专家共识》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 May 10;43(5):609-626. doi: 10.3760/cma.j.cn112338-20220402-00253.
6
Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.骨骼肌量和腹型肥胖是肝脂肪变性的独立预测因子,两者相互作用可预测十年心血管疾病的发生率:来自 ATTICA 队列研究的数据。
Clin Nutr. 2022 Jun;41(6):1281-1289. doi: 10.1016/j.clnu.2022.03.022. Epub 2022 Mar 31.
7
Menopause-associated risk of cardiovascular disease.绝经相关的心血管疾病风险。
Endocr Connect. 2022 Apr 22;11(4):e210537. doi: 10.1530/EC-21-0537.
8
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases.肥胖的病理生理分子机制:MAFLD 和 NASH 与心血管疾病的联系。
Int J Mol Sci. 2021 Oct 27;22(21):11629. doi: 10.3390/ijms222111629.
9
Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.非酒精性脂肪性肝病与糖尿病、慢性肾脏病和心血管疾病的关联:一项在中国进行的4.6年队列研究
J Clin Endocrinol Metab. 2022 Jan 1;107(1):88-97. doi: 10.1210/clinem/dgab641.
10
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.非酒精性脂肪性肝病与主要不良心血管事件的发生:一项全国性组织学队列研究结果
Gut. 2022 Sep;71(9):1867-1875. doi: 10.1136/gutjnl-2021-325724. Epub 2021 Sep 6.